trending Market Intelligence /marketintelligence/en/news-insights/trending/uE_00NpKMnlQym7xb2V3jA2 content esgSubNav
In This List

XOMA closes rights offering

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


XOMA closes rights offering

XOMA Corp. closed its previously announced rights offering, raising $20 million.

The Emeryville, Calif.-based drug developer sold 285,689 common shares at $13 apiece and 1,252.772 series Y preferred shares at $13,000 apiece.

Existing stockholders bought 570.126 of the series Y preferred shares, while BVF Partners LP, XOMA's largest stockholder, exercised its oversubscription rights and acquired the remaining 682.646 series Y preferred shares.

D.F. King & Co. Inc. acted as information agent for the rights offering.